Northwestern Mutual Wealth Management Co. lifted its holdings in Cabot Corporation (NYSE:CBT – Free Report) by 56,330.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 107,218 shares of the specialty chemicals company’s stock after buying an additional 107,028 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Cabot were worth $7,106,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Ashton Thomas Private Wealth LLC grew its position in shares of Cabot by 343.9% in the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 65,561 shares of the specialty chemicals company’s stock worth $4,986,000 after buying an additional 50,792 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Cabot by 5.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,556,762 shares of the specialty chemicals company’s stock worth $118,392,000 after buying an additional 73,734 shares during the period. Elo Mutual Pension Insurance Co purchased a new stake in shares of Cabot in the 3rd quarter worth about $1,040,000. Royce & Associates LP grew its position in shares of Cabot by 37.5% in the 3rd quarter. Royce & Associates LP now owns 106,980 shares of the specialty chemicals company’s stock worth $8,136,000 after buying an additional 29,202 shares during the period. Finally, UBS Group AG grew its position in shares of Cabot by 3.5% in the 4th quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock worth $40,708,000 after buying an additional 20,668 shares during the period. 93.18% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
CBT has been the topic of a number of recent research reports. JPMorgan Chase & Co. upped their target price on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research report on Wednesday, May 13th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Mizuho upped their price target on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Finally, UBS Group upped their price target on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research note on Friday, May 8th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cabot has an average rating of “Hold” and a consensus target price of $80.25.
Cabot Price Performance
Shares of NYSE:CBT opened at $83.42 on Friday. The firm’s 50 day moving average price is $75.88 and its 200-day moving average price is $71.34. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $86.43. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $4.31 billion, a PE ratio of 15.77, a price-to-earnings-growth ratio of 10.25 and a beta of 0.78.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.31 million. During the same quarter in the prior year, the business earned $1.90 EPS. The business’s quarterly revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Equities research analysts expect that Cabot Corporation will post 6.32 EPS for the current year.
Cabot Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be paid a $0.4725 dividend. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. Cabot’s dividend payout ratio (DPR) is currently 34.03%.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Further Reading
- Five stocks we like better than Cabot
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
